Citadel Advisors - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 19 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q4 2018$26,000
+8.3%
140,947
+35.7%
0.00%
Q3 2018$24,000
+33.3%
103,887
+88.8%
0.00%
Q2 2018$18,000
-77.2%
55,020
-72.6%
0.00%
Q1 2018$79,000
+393.8%
200,749
+326.3%
0.00%
Q4 2017$16,00047,0960.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Occidental Asset Management, LLC 15,834$6,0000.00%
Virtu Financial LLC 34,330$14,0000.00%
Waldron Private Wealth LLC 11,000$4,0000.00%
VANGUARD GROUP INC 451,169$178,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,080$00.00%
UBS Group AG 1,714$1,0000.00%
Well Done, LLC 190$00.00%
Advisor Group, Inc. 250$00.00%
Jacobi Capital Management LLC 318$00.00%
CITY HOLDING CO 417$00.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders